- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04604457
Impact of Predictive Modeling on Time to Palliative Care in an Outpatient Primary Care Population
14. juni 2021 opdateret af: Rachel D. Havyer, Mayo Clinic
A machine learning algorithm will be used to accurately identify patients in certain primary care units who may benefit from palliative care consults.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
A machine learning algorithm will be used to accurately identify patients in certain primary care units who may benefit from palliative care consults.
These patients will be presented weekly to a palliative care specialist in a custom user interface.
The palliative care specialist will reach out to primary care teams if she determines that the patient would benefit from palliative care.
If the primary care provider agrees, he/she would write a palliative care consult order for the patient.
The goal is to reduce the time to palliative care for these patients, who may not have been identified as quickly without the algorithm.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
127070
Fase
- Ikke anvendelig
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Minnesota
-
Rochester, Minnesota, Forenede Stater, 55905
- Mayo Clinic in Rochester
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
18 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- Adult patient assigned to a primary care unit from July 2020 to June 2021.
- Weekly the palliative care specialists will select patients by looking at patients in sorted order starting with the highest score and proceeding down the list and evaluating each patient for exclusion criteria.
Exclusion Criteria:
- Patients that have been seen by Palliative care will be excluded for 75 days
- Patients under the age of 18 years.
- Patients currently enrolled with hospice
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Screening
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Standard of Care
Palliative care specialists would not reach out to primary care providers.
Palliative care needs would be met via existing mechanisms.
|
|
|
Eksperimentel: Predictive Model
Palliative care specialists review recommendations from the predictive model and contact a patient's primary care provider (PCP) when appropriate to recommend a palliative care consult.
|
Palliative care specialist reaches out to primary care to recommend a palliative care consult.
If the primary care provider agrees, he/she will write an order for a palliative care consult.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Timely identification for need of palliative care
Tidsramme: Through study completion, an average of 1 year
|
Time to electronic record of consult by the palliative care team in the outpatient setting
|
Through study completion, an average of 1 year
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Number of palliative care consults
Tidsramme: Through study completion, an average of 1 year
|
Number of palliative care consults that occurred on intervention and standard of care arms
|
Through study completion, an average of 1 year
|
|
Number of advanced care planning notes documented in the EHR
Tidsramme: Through study completion, an average of 1 year
|
Number of advanced care planning notes documented in the EHR on both arms
|
Through study completion, an average of 1 year
|
|
Number of billing codes for palliative care
Tidsramme: Through study completion, an average of 1 year
|
Number of ICD-10 billing codes for palliative care on both arms
|
Through study completion, an average of 1 year
|
|
Positive predictive value of screened patients
Tidsramme: Through study completion, an average of 1 year
|
Percentage of screened patients that received palliative care consults
|
Through study completion, an average of 1 year
|
|
Percent of patients who are eligible for ECH based palliative care
Tidsramme: Through study completion, an average of 1 year
|
Percent of patients who are eligible for employee/community health (ECH) based palliative care compared to the Palliative Care Clinic.
|
Through study completion, an average of 1 year
|
|
Percent agreement between Palliative Care and Primary Care and average time between Primary Care Contact and Response
Tidsramme: Through study completion, an average of 1 year
|
Agreement statistics (percent agreement and Kappa statistics) between Palliative Care and Primary Care and descriptive statistics (mean, etc.) on time between primary care contact and response.
|
Through study completion, an average of 1 year
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Rachel Havyer, MD, Mayo Clinic
Publikationer og nyttige links
Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.
Hjælpsomme links
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
31. august 2020
Primær færdiggørelse (Faktiske)
31. maj 2021
Studieafslutning (Faktiske)
31. maj 2021
Datoer for studieregistrering
Først indsendt
14. oktober 2020
Først indsendt, der opfyldte QC-kriterier
21. oktober 2020
Først opslået (Faktiske)
27. oktober 2020
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
16. juni 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
14. juni 2021
Sidst verificeret
1. juni 2021
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- 20-005977
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
INGEN
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Palliativ pleje
-
Xuzhou Medical UniversityIkke rekrutterer endnuIkke-invasiv CAR-T-celleovervågning | BCMA-målrettet PET-skanning | CAR-T-cellebiodistribution og -persistens | GMP-overensstemmende Radiopharmaka-præparation
-
The Affiliated Hospital of Xuzhou Medical UniversityRekrutteringCLL | SLL | CAR-T celleterapiKina
-
Duke UniversityNational Institutes of Health (NIH)RekrutteringHæmatopoietisk stamcelletransplantation | CAR-T celleterapiForenede Stater
-
Azienda Usl di BolognaIRCCS Azienda Ospedaliero-Universitaria di BolognaAfsluttetPalliativ pleje | Palliativ medicin | Hospice og palliativ sygeplejeItalien
-
Stiftung Swiss Tumor InstituteKlinik Hirslanden, Zurich; Palleos Healthcare GmbHRekrutteringPatientrapporterede resultatmål | CAR T-celleterapiSchweiz
-
Patrick C. Johnson, MDRekruttering
-
University Health Network, TorontoIkke rekrutterer endnuLymfom, der modtager CAR-T-terapiCanada
-
The Lymphoma Academic Research OrganisationBristol-Myers Squibb; Novartis; Gilead SciencesRekrutteringHæmatopatologi kvalificeret eller CAR-t-cellebehandlingFrankrig
-
IRCCS Azienda Ospedaliero-Universitaria di BolognaRekrutteringCAR-T Terapi KomplikationerItalien
-
University Medical Center GoettingenRekrutteringPalliativ pleje | Palliativ pleje, patientbehandling | Oral sundhedspleje | Oral sundhedsrelateret livskvalitetTyskland
Kliniske forsøg med Palliative care contacts primary care
-
Xuanwu Hospital, BeijingBioray LaboratoriesIkke rekrutterer endnuMultipel sclerose | Neuromyelitis Optica Spectrum Disorders | Kronisk inflammatorisk demyeliniserende polyradiculoneuropati | Myasthenia Gravis, generaliseretKina
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterende
-
The Second Hospital of Shandong UniversityAktiv, ikke rekrutterendeSikkerhed og effektivitet af cellulære lægemidler, objektiv responsrate for forsøgspersoner osvKina
-
Cellular Biomedicine Group Ltd.The First Affiliated Hospital with Nanjing Medical UniversityAfsluttetRefraktært diffust stort B-cellet lymfomKina
-
Beijing BiotechRekrutteringHER2-positiv brystkræft | Triple-negativ brystkræft | Brystkræft (Avanceret/Metastatisk)Kina
-
University of California, San FranciscoTrukket tilbageLymfom | Leukæmi | Plasmacelledyskrasi
-
Zhejiang UniversityCarbiogene Therapeutics Co. Ltd.RekrutteringKlinisk forsøg med autologe GPC3 CAR-T-celler (CBG166) terapi for avanceret hepatocellulært karcinomAvanceret hepatocellulært karcinomKina
-
Nexcella Inc.Immix Biopharma, Inc.RekrutteringLet kæde (AL) amyloidoseForenede Stater
-
Second Affiliated Hospital, School of Medicine,...RekrutteringRecidiverende og refraktær B-celle lymfomKina
-
Second Affiliated Hospital, School of Medicine,...Rekruttering